Goserelin acetate before transurethral resection of moderately enlarged benign prostatic hyperplasia: Prospective randomised-controlled clinical trial.

Journal: Arab journal of urology
Published Date: Nov 21, 2015

Abstract

OBJECTIVE: To evaluate the impact of a luteinising hormone-releasing hormone (LHRH) agonist, goserelin acetate (GA), on surgical blood loss during transurethral resection of the prostate (TURP), as well as its histopathological effect on prostatic microvessel density (MVD).

Authors

  • Mohamed Abo El-Enen
    Departments of Urology, Faculty of Medicine, Tanta University, Tanta, Egypt.
  • Ahmed Tawfik
    Departments of Urology, Faculty of Medicine, Tanta University, Tanta, Egypt.
  • Ahmed S El-Abd
    Departments of Urology, Faculty of Medicine, Tanta University, Tanta, Egypt.
  • Maged Ragab
    Departments of Urology, Faculty of Medicine, Tanta University, Tanta, Egypt.
  • Sherin El-Abd
    Departments of Histology, Faculty of Medicine, Tanta University, Tanta, Egypt.
  • Mohamed Elrashidy
    Departments of Pathology, Faculty of Medicine, Tanta University, Tanta, Egypt.
  • Nehal Elmashad
    Departments of Medical Oncology, Faculty of Medicine, Tanta University, Tanta, Egypt.
  • Mohamed Rasheed
    Departments of Urology, Faculty of Medicine, Tanta University, Tanta, Egypt.
  • Shawky El-Abd
    Departments of Urology, Faculty of Medicine, Tanta University, Tanta, Egypt.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals